These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
457 related items for PubMed ID: 27634113
1. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine. Eschbaumer M, Stenfeldt C, Rekant SI, Pacheco JM, Hartwig EJ, Smoliga GR, Kenney MA, Golde WT, Rodriguez LL, Arzt J. BMC Vet Res; 2016 Sep 15; 12():205. PubMed ID: 27634113 [Abstract] [Full Text] [Related]
2. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge. Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG. Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216 [Abstract] [Full Text] [Related]
3. The Foot-and-Mouth Disease Carrier State Divergence in Cattle. Stenfeldt C, Eschbaumer M, Rekant SI, Pacheco JM, Smoliga GR, Hartwig EJ, Rodriguez LL, Arzt J. J Virol; 2016 Jul 15; 90(14):6344-64. PubMed ID: 27147736 [Abstract] [Full Text] [Related]
4. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ. Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486 [Abstract] [Full Text] [Related]
6. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model. Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA. BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853 [Abstract] [Full Text] [Related]
7. Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle. Stenfeldt C, Eschbaumer M, Pacheco JM, Rekant SI, Rodriguez LL, Arzt J. PLoS One; 2015 Aug 29; 10(11):e0143666. PubMed ID: 26599543 [Abstract] [Full Text] [Related]
9. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT. Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951 [Abstract] [Full Text] [Related]
10. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection. Pega J, Di Giacomo S, Bucafusco D, Schammas JM, Malacari D, Barrionuevo F, Capozzo AV, Rodríguez LL, Borca MV, Pérez-Filgueira M. J Virol; 2015 Sep 30; 89(18):9581-90. PubMed ID: 26157128 [Abstract] [Full Text] [Related]
11. Transcriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the Nasopharynx. Eschbaumer M, Stenfeldt C, Smoliga GR, Pacheco JM, Rodriguez LL, Li RW, Zhu J, Arzt J. PLoS One; 2016 Sep 30; 11(9):e0162750. PubMed ID: 27643611 [Abstract] [Full Text] [Related]
12. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Eblé PL, de Bruin MG, Bouma A, van Hemert-Kluitenberg F, Dekker A. Vaccine; 2006 Feb 27; 24(9):1274-81. PubMed ID: 16289709 [Abstract] [Full Text] [Related]
13. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Hutchings G, Paton DJ, Barnett PV. Vaccine; 2006 Apr 12; 24(16):3184-90. PubMed ID: 16488060 [Abstract] [Full Text] [Related]
14. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle. Moonen P, Jacobs L, Crienen A, Dekker A. Vet Microbiol; 2004 Nov 15; 103(3-4):151-60. PubMed ID: 15504586 [Abstract] [Full Text] [Related]
15. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ. Vet Microbiol; 2017 May 15; 203():196-201. PubMed ID: 28619144 [Abstract] [Full Text] [Related]
16. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep. Singanallur NB, Pacheco JM, Arzt J, Stenfeldt C, Fosgate GT, Rodriguez L, Vosloo W. Antiviral Res; 2017 Sep 15; 145():114-122. PubMed ID: 28780422 [Abstract] [Full Text] [Related]
17. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves. Di Giacomo S, Brito BP, Perez AM, Bucafusco D, Pega J, Rodríguez L, Borca MV, Pérez-Filgueira M. Transbound Emerg Dis; 2015 Jun 15; 62(3):280-7. PubMed ID: 23895140 [Abstract] [Full Text] [Related]
18. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Eblé PL, Bouma A, Weerdmeester K, Stegeman JA, Dekker A. Vaccine; 2007 Jan 22; 25(6):1043-54. PubMed ID: 17157418 [Abstract] [Full Text] [Related]
19. Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles. Bucafusco D, Di Giacomo S, Pega J, Schammas JM, Cardoso N, Capozzo AV, Perez-Filgueira M. Virology; 2015 Feb 22; 476():11-18. PubMed ID: 25496826 [Abstract] [Full Text] [Related]
20. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine. Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG. Vaccine; 2018 Nov 19; 36(48):7345-7352. PubMed ID: 30327212 [Abstract] [Full Text] [Related] Page: [Next] [New Search]